SC
EXAC

Sophrosyne Capital’s Exactech Inc EXAC Stock Holding History

Sophrosyne Capital’s Portfolio EXAC Stock Details EXAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-33,700
Closed -$679K – 79
2013
Q3 		$679K Buy
+33,700
New +$675K 0.45% 45

Other funds holding EXAC

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.5B AUM 31.02% 1-Year Est. Return

Sophrosyne Capital's EXAC Position: Q4 2013 in Review

Sophrosyne Capital sold out of Exactech Inc (EXAC) in Q4 2013, closing a stake of 33,700 shares — an estimated $679K sold.

Sophrosyne Capital first reported a position in EXAC in Q3 2013 and held it in 1 quarter. The position peaked at $679K in Q3 2013. 82 funds tracked by Wall St. Rank hold EXAC as of Q4 2013.

  • Sophrosyne Capital reported no remaining Exactech Inc position as of Q4 2013 after selling out during the quarter.
  • Sophrosyne Capital sold 33,700 Exactech Inc shares in Q4 2013, an estimated $679K.
  • Sophrosyne Capital first reported a position in Exactech Inc in Q3 2013 and held it in 1 quarter.
  • Sophrosyne Capital's Exactech Inc position peaked at $679K in Q3 2013.
  • 82 funds tracked by Wall St. Rank held Exactech Inc as of Q4 2013.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.